Investor Group Led by Chris Brengard and Management (with Bain, Summit, Revelstoke, Mark Caputo) Acquires U.S. Renal Care
February 13, 2019
U.S. Renal Care, a Plano, Texas-based provider of dialysis services, entered into a definitive agreement to be acquired by a private investor group led by CEO Chris Brengard and the U.S. Renal management team alongside Bain Capital Private Equity, Summit Partners, Revelstoke Capital Partners, and investor Mark Caputo. The management team will remain significant investors; financial terms were not disclosed and the transaction remains subject to customary closing conditions and regulatory approvals.
- Buyers
- Chris Brengard and the U.S. Renal Care management team, Bain Capital Private Equity, Summit Partners, Revelstoke Capital Partners, Mark Caputo
- Targets
- U.S. Renal Care, Inc.
- Sellers
- Leonard Green & Partners, Frazier Healthcare Partners, New Enterprise Associates, Inc., Cressey & Company
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
The Brydon Group Leads Majority Investment in Renesan and Visonex
August 14, 2023
Healthcare Services
The Brydon Group led a majority investment to combine Renesan and Visonex, two U.S.-based providers of cloud-based software for dialysis clinics. The combined company will be led by executives from both firms (Chris Sigala as CEO) and will use the new capital to accelerate product development and expand healthcare IT offerings for kidney care providers.
-
Ren Receives Strategic Growth Investment from Bain Capital Tech Opportunities and Valeas Capital Partners
July 26, 2023
Cloud & SaaS
Ren, an Indianapolis-based provider of donor-advised fund enablement software and services, received a strategic growth investment led by Bain Capital Tech Opportunities and Valeas Capital Partners. The capital — Ren's first institutional funding — will be used to build new product features, rapidly scale the team, increase advisor and client awareness of donor-advised funds, and expand Ren's charity network; financial terms were not disclosed. Raymond James acted as exclusive financial advisor.
-
Pharos Capital Invests in Renal Care 360°
September 1, 2022
Healthcare Services
Pharos Capital Group made a significant growth investment in Renal Care 360°, a nephrology practice and chronic kidney disease management company led by founder Joe Cashia. The capital (terms undisclosed) will support scaling the RC360° Connected Care Program, geographic expansion through acquisitions, and development of value-based care capabilities while Mr. Cashia remains Chairman and CEO.
-
Carrick Capital Partners Invests in Renalogic (Growth Recapitalization)
March 3, 2021
Healthcare Services
Carrick Capital Partners has made a growth recapitalization investment in Renalogic, a provider of dialysis risk management and chronic kidney disease (CKD) cost-containment solutions. The investment will support Renalogic's expansion of services — including its predictive analytics/AI platform CareINSIGHTS.ai — to scale support for self-funded employers, health plans and stop-loss carriers.
-
Innovative Renal Care (Nautic Partners) to Acquire American Renal Associates
October 5, 2020
Healthcare Services
Innovative Renal Care, an affiliate of Nautic Partners, has entered into a definitive all-cash agreement to acquire American Renal Associates Holdings, Inc. for an enterprise value of approximately $853 million (ARA shareholders to receive $11.50 per share). The transaction, financed in part by HPS Investment Partners and subject to customary approvals and a 40-day go-shop, is expected to close in Q1 2021.
-
Revelstoke Capital Partners Recapitalizes The Care Team
October 15, 2019
Healthcare Services
Denver-based private equity firm Revelstoke Capital Partners has completed a recapitalization of The Care Team, a Farmington Hills, Michigan-based home health and hospice provider. The investment will provide capital and strategic support to accelerate TCT's growth, pursue multi-state expansion and participate in industry consolidation while founder Jason Laing remains CEO and a significant shareholder.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.